News, The F.D.A. in Crisis: Another Danger Made in China. (treat, patients)

[JD59]

The F.D.A. — and American consumers — got another warning last week about the need for vigilant monitoring of imported drugs from the developing world, especially from China. The contamination of a drug used to treat Chinese leukemia patients should also raise alarms at multinational pharmaceutical companies that plan to outsource manufacturing to China.

The F.D.A. in Crisis: Another Danger Made in China - New York Times